* [[Cannabinoid receptor antagonist/ja|カンナビノイド受容体拮抗薬]]が肥満治療のために開発されたのは、カンナビノイド作動薬（[[cannabis/ja|大麻]]の主薬理学的活性成分で
* 一部の減量薬は、神経伝達物質である[[serotonin/ja|セロトニン]]、[[dopamine/ja|ドーパミン]]、[[norepinephrine/ja|ノルエピネフリン]]に作用して食欲を減退させる。
...
22 KB (659 words) - 09:48, 8 March 2024
...nist|坑ドーパミン薬]], [[proton pump inhibitor|プロトンポンプ阻害剤]] (PPIs), [[H2 receptor antagonist|H<sub>2</sub>-受容体拮抗薬]], [[Cytoprotection|細胞保護剤]], [[prostaglandin analogue|
...rtensive drug|降圧薬]]: [[ACE inhibitor/ja|ACE阻害薬]]、[[Angiotensin II receptor antagonist/ja|アンジオテンシン受容体拮抗薬]]、[[beta-blocker/ja|β遮断薬]]、[[alpha blocker/ja|α遮断薬]]、[[ca
...
58 KB (1,845 words) - 17:09, 5 November 2023
*[[Cannabinoid receptor antagonist]]s were developed to treat obesity because researchers noticed that cannabi
*Some weight loss drugs act on the neurotransmitters [[serotonin]], [[dopamine]], and [[norepinephrine]] to reduce appetite.
...
17 KB (2,406 words) - 18:16, 7 March 2024
*[[Cannabinoid receptor antagonist]]s were developed to treat obesity because researchers noticed that cannabi
*Some weight loss drugs act on the neurotransmitters [[serotonin]], [[dopamine]], and [[norepinephrine]] to reduce appetite.
...
18 KB (2,460 words) - 18:15, 7 March 2024
| -lukast || [[Leukotriene]] [[receptor antagonist]]s<ref name=AMA /> || [[zafirlukast]], [[montelukast]]
| -axine || [[Dopamine]] and [[serotonin–norepinephrine reuptake inhibitor]]<ref name=AMA /> || [[
...
25 KB (3,297 words) - 17:05, 3 January 2023
...minergics]], [[proton pump inhibitor|proton pump inhibitor]]s (PPIs), [[H2 antagonist|H<sub>2</sub>-receptor antagonists]], [[cytoprotectant|cytoprotectant]]s, [
...sive drug]]s): [[ACE inhibitor|ACE inhibitor]]s, [[Angiotensin II receptor antagonist|angiotensin receptor blockers]], [[beta-blocker|beta-blocker]]s, [[alpha bl
...
52 KB (6,923 words) - 17:09, 5 November 2023
...minergics]], [[proton pump inhibitor|proton pump inhibitor]]s (PPIs), [[H2 antagonist|H<sub>2</sub>-receptor antagonists]], [[cytoprotectant|cytoprotectant]]s, [
...sive drug]]s): [[ACE inhibitor|ACE inhibitor]]s, [[Angiotensin II receptor antagonist|angiotensin receptor blockers]], [[beta-blocker|beta-blocker]]s, [[alpha bl
...
54 KB (7,245 words) - 17:08, 5 November 2023
...drugs. Typically it includes pharmacological [[agonists]] and [[Receptor antagonist|antagonists]], but also [[enzyme]] inhibitors (such as [[monoamine oxidase]
...and include [[acetylcholine]], [[adrenaline]], [[glutamate]], [[GABA]], [[dopamine]], [[histamine]], [[serotonin]], [[cannabinoid]] and [[opioid]].
...
30 KB (3,998 words) - 20:36, 8 January 2023
...the biosynthesis of five important [[neurotransmitters]]: [[serotonin]], [[dopamine]], [[epinephrine]], [[norepinephrine]], and [[gamma-aminobutyric acid]].
...min B<sub>6</sub>, because the [[ginkgotoxin]] is an anti-vitamin (vitamin antagonist). Symptoms include vomiting and generalized convulsions. Ginkgo seed poison
...
32 KB (4,586 words) - 16:32, 3 April 2024
...the biosynthesis of five important [[neurotransmitters]]: [[serotonin]], [[dopamine]], [[epinephrine]], [[norepinephrine]], and [[gamma-aminobutyric acid]].
...min B<sub>6</sub>, because the [[ginkgotoxin]] is an anti-vitamin (vitamin antagonist). Symptoms include vomiting and generalized convulsions. Ginkgo seed poison
...
32 KB (4,696 words) - 16:32, 3 April 2024
...drugs. Typically it includes pharmacological [[agonists]] and [[Receptor antagonist|antagonists]], but also [[enzyme]] inhibitors (such as [[monoamine oxidase]
...and include [[acetylcholine]], [[adrenaline]], [[glutamate]], [[GABA]], [[dopamine]], [[histamine]], [[serotonin]], [[cannabinoid]] and [[opioid]].
...
46 KB (5,967 words) - 12:23, 15 November 2023